ADAP - Adaptimmune Therapeutics plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts6666
Avg. Estimate-0.31-0.31-1.21-1.15
Low Estimate-0.35-0.35-1.39-1.37
High Estimate-0.26-0.29-0.93-0.9
Year Ago EPS-0.22-0.48-0.96-1.21
Revenue EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts8888
Avg. Estimate2M1.63M9.1M13.29M
Low EstimateN/AN/AN/A1M
High Estimate4M3M24M36M
Year Ago Sales8.2M9.04M59.51M9.1M
Sales Growth (year/est)-75.60%-82.00%-84.70%46.00%
Earnings History3/30/20186/29/20189/29/201812/30/2018
EPS Est.-0.24-0.27-0.06-0.32
EPS Actual-0.22-0.480.06-0.36
Difference0.02-0.210.12-0.04
Surprise %8.30%-77.80%200.00%-12.50%
EPS TrendCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.31-0.31-1.21-1.15
7 Days Ago-0.31-0.31-1.21-1.15
30 Days Ago-0.32-0.32-1.21-1.15
60 Days Ago-0.32-0.33-1.18-1.33
90 Days Ago-0.32-0.33-1.18-1.33
EPS RevisionsCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days11N/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesADAPIndustrySectorS&P 500
Current Qtr.-40.90%N/AN/A-0.01
Next Qtr.35.40%N/AN/A0.04
Current Year-26.00%N/AN/A0.05
Next Year5.00%N/AN/A0.11
Next 5 Years (per annum)1.00%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A